Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Diffractaic acid is a lichen metabolite that has been found in P. magellanica and has diverse biological activities.1,2,3,4 It is cytotoxic to HCT116, HeLa, and MCF-7 cancer cells (IC50s = 42.2, 64.6, and 93.4 μM, respectively).1 Diffractaic acid inhibits growth of M. tuberculosis (MIC = 41.7 μM).2 In vivo, diffractaic acid (25-200 mg/kg) reduces neutrophil infiltration, lipid peroxidation, myeloperoxidase (MPx) activity, and the number of gastric lesions as well as reverses decreases in superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities induced by indomethacin (Item No. 70270) in rat gastric mucosa.3 Diffractaic acid also has analgesic activity, reducing acetic acid-induced writhing and increasing the pressure pain threshold in mice.4
WARNING This product is not for human or veterinary use.
1. Cytotoxic activity and antioxidant capacity of purified lichen metabolites: An in vitro study. Phytother. Res. 27(3), 431-437 (2013).
2. Antimycobacterial activity of lichen substances. Phytomedicine 17(5), 328-332 (2010).
3. The inhibition of gastric mucosal lesion, oxidative stress and neutrophil-
4. Usnic acid and diffractaic acid as analgesic and antipyretic components of Usnea diffracta. Planta Med. 61(2), 113-115 (1995).